Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Data from prospective epidemiological studies in Asian populations and from experimental studies in animals and cell lines suggest a possible protective association between dietary isoflavones and the development of prostate cancer. We examined the association between circulating concentrations of genistein and prostate cancer risk in a case-control study nested in the European Prospective Investigation into Cancer and Nutrition.Concentrations of the isoflavone genistein were measured in prediagnostic plasma samples for 1,605 prostate cancer cases and 1,697 matched control participants. Relative risks (RRs) for prostate cancer in relation to plasma concentrations of genistein were estimated by conditional logistic regression.Plasma genistein concentrations were not associated with prostate cancer risk; the multivariate relative risk for men in the highest fifth of genistein compared with men in the lowest fifth was 1.00 (95 % confidence interval: 0.79, 1.27; p linear trend = 0.82). There was no evidence of heterogeneity in this association by age at blood collection, country of recruitment, or cancer stage or histological grade.Plasma genistein concentration was not associated with prostate cancer risk in this large cohort of European men.

Original publication

DOI

10.1007/s10552-012-9985-y

Type

Journal article

Journal

Cancer causes & control : CCC

Publication Date

07/2012

Volume

23

Pages

1163 - 1171

Addresses

Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, UK. ruth.travis@ceu.ox.ac.uk

Keywords

Humans, Prostatic Neoplasms, Genistein, Chromatography, High Pressure Liquid, Registries, Multivariate Analysis, Logistic Models, Risk Assessment, Risk Factors, Case-Control Studies, Prospective Studies, Adult, Aged, Middle Aged, Europe, Male, Tandem Mass Spectrometry, Surveys and Questionnaires